Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (278)	2/11/2003 12:02:39 PM
From: Jibacoa	Read Replies (2) \| Respond to of 3722

CRIS Seems to have found support at the $0.75 level.<g> (In spite of its good size loss in the last 12 months CRIS still reportedly has $0.76 cash/share and that may be enough to carry it for a full year at its reduced burn rate in the last Q.) In the 12 months loss it was included a $69M "goodwill and patent impairment charge" and $3.5M of "realignment expenses".<g> CRIS announced today good results of its BMP-7 protein,which reportedly can improve motor function after a CVA even when it is given IV 24hrs. after the injury. (Previous reports have shown that BMP-7 could be of benefit when given up to three days after a CVA, but in previous studies it was injected directly into the cerebrospinal fluid. The insiders reportedly have bought 74K and institutions 66K lately.<g> The stock needs to close above its Jan.2 H of 1.20 (that already would be a good % gain <g>), before the chart starts to look better and the stock can test its Nov.26 H at 1.28 and its September 26 H at 1.37.(After that the next hurdle would be its May 24 H at 1.67) siliconinvestor.com From a longer term perspective the R/R appears favorable at present levels.<g> siliconinvestor.com Bernard